GCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.

Routine, Ultra-Trace Analysis of Nitrosamines in Drugs using Gas-Chromatography – Orbitrap Mass Spectrometry

Postery | 2020 | Thermo Fisher Scientific | ASMSInstrumentace
GC/MSD, GC/MS/MS, GC/HRMS, GC/Orbitrap
Zaměření
Farmaceutická analýza
Výrobce
Thermo Fisher Scientific
Klíčová slova
PDF verze ke stažení a čtení
 

Podobná PDF

Toggle
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Technické články
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Klíčová slova
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapmass, massaquisition, aquisitionexactive, exactivesource, sourceloop, loopkpa
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Klíčová slova
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapaquisition, aquisitionmass, massexactive, exactiveloop, loopsource, sourcekpa
Nitrosamine impurities analysis solution guide
2021|Thermo Fisher Scientific|Příručky
Nitrosamine impurities analysis solution guide • Find the right analytical solution for each stage of nitrosamine impurity analysis • Confidently detect and quantify genotoxic impurities in active pharmaceutical ingredients and finished drug products Table of contents Monitoring genotoxic impurities in…
Klíčová slova
nitrosamine, nitrosaminepage, pagehram, hramcontents, contentsnext, nextimpurity, impurityback, backresources, resourceslearn, learnmetformin, metforminsoftware, softwarevalsartan, valsartansolution, solutionmass, massthermo
Application Note No. 62 Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances Dheeraj Handique *a), Nitish Suryawanshi *a), Crystal Yeong *b), Cynthia Lahey *b), Shailendra Rane *a), Deepti Bhandarkar *a), Anant Lohar *a), Gao Jie san *c),…
Klíčová slova
ndma, ndmandea, ndeacarcinogenic, carcinogenicsubstances, substancesmutagenic, mutagenicmms, mmsems, emsimpurity, impuritymode, modeims, imsmutagenicity, mutagenicitydrug, drugolmesartan, olmesartanndba, ndbapharmaceuticals
Další projekty
Sledujte nás
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.